Healthcare in India is changing fast. One of the most powerful drivers of this change is innovation—especially innovation that focuses on affordability and accessibility. That’s exactly what Cureous Labs is doing.
Based in Bengaluru, this healthcare technology startup is building affordable medical devices to help patients who are bedridden. Their goal is simple but impactful: improve patient comfort and reduce caregiver burden—without making it expensive or complicated.
A Mission Born from Real-World Need
The story of Cureous Labs starts in 2019. Asish Mohandas, a Biodesign fellow from All India Institute of Medical Sciences (AIIMS) and alumnus of Indian Institute of Technology Delhi (IIT Delhi), saw a critical problem in hospitals and home care setups across India.
Many patients who are bedridden for long periods suffer from pressure ulcers (bedsores). These are painful wounds caused by staying in the same position too long. Preventing them requires regular patient turning and repositioning—something that’s time-consuming, physically demanding, and often difficult for caregivers.
While high-end automated turning systems exist abroad, they cost several lakhs of rupees, making them out of reach for most Indian hospitals and families. Asish saw this gap as an opportunity: to create a device that delivers the same benefits at a fraction of the cost.
This idea eventually grew into Cureous Labs in 2020—a company with a strong social mission and a clear product vision.
Building Innovation through Collaboration
Cureous Labs isn’t a one-man show. It was formed by a team of doctors, biomedical engineers, and healthcare experts who brought their unique skills together. Their foundation was built on evidence-based innovation.
Unlike many startups that jump straight into development, Cureous Labs first spent months understanding real user problems—talking to caregivers, nurses, doctors, and patient families. This helped them design a product that was practical, user-friendly, and cost-effective.
They also collaborated with hospitals and research institutions to make sure their solution could withstand real-world clinical settings.
Turning Research into Real-World Products
One of the key strengths of Cureous Labs is its commitment to testing. Before launching its product, the team conducted clinical trials in more than 30 hospitals across India and Australia.
These trials allowed them to:
- Validate the safety and performance of their device.
- Refine the product design based on feedback from healthcare professionals.
- Prove that the technology works reliably over long-term use.
- Build trust with hospitals and investors.
Their primary product, Eturnal, went through rigorous testing—showing that innovation doesn’t have to be rushed to make an impact.
Meet Eturnal: An Affordable Bed-Turning Solution
Eturnal is Cureous Labs’ flagship product. It is an automated turning and positioning system that helps caregivers turn bedridden patients at regular intervals—without heavy physical effort.
Here’s what makes Eturnal stand out:
- Cost-effective: It’s nearly 80% cheaper than imported alternatives.
- Versatile: Suitable for use in hospitals, nursing homes, and even at home.
- Proven performance: Over 30,000 patient turns and 14,000 automated cycles have already been completed during pilot deployments.
- Ease of use: Designed with simplicity in mind so even non-medical caregivers can operate it confidently.
- Prevents complications: Regular turning helps reduce the risk of pressure injuries, infections, and other mobility-related health problems.
Eturnal has already entered pilot trials in several hospitals across South India, with plans to expand nationwide in the coming months.
Funding That Fuels Innovation
In early 2025, Cureous Labs secured $1.66 million in seed funding, led by Inflection Point Ventures with support from Anthill Ventures.
The funds will be used to:
- Begin commercial manufacturing of Eturnal.
- Build sufficient inventory to meet early demand.
- Expand their sales, marketing, and customer support teams.
- Establish disinfection and maintenance facilities.
- Obtain international certifications for safety and compliance.
- Strengthen their B2B presence in the Indian healthcare market.
This funding round isn’t just about money. It’s a validation of their vision—investors are betting on the idea that affordable med-tech will define the future of healthcare in India.
The Bigger Picture: A Booming Healthcare Market
The elder care and bedridden patient care market is growing rapidly worldwide, valued at nearly $277 billion. India alone is expected to reach $8.34 billion in this segment.
With an aging population, rising chronic illness rates, and growing home-care trends, affordable healthcare solutions like Eturnal are in high demand.
Cureous Labs isn’t just building a product—it’s positioning itself in a market with massive growth potential.
A Vision That Goes Beyond Profit
What sets Cureous Labs apart is its mission-driven approach. The company’s vision is to enable safer, more dignified care for patients with mobility issues. They want to make advanced patient-care technology accessible to every hospital, caregiver, and family—not just the wealthy few.
Their long-term plan includes developing more products to prevent bed falls, enhance patient mobility, and simplify caregiving.
About Marketing Mirrors
This article was crafted by Marketing Mirrors, a content and SEO storytelling studio that helps businesses and startups turn their journeys into powerful narratives.
Marketing Mirrors specializes in creating engaging, SEO-optimized content that connects emotionally with readers while ranking effectively on search engines. With a focus on clarity, strategy, and storytelling, we help brands build trust, attract the right audience, and scale faster.
